Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Wolska

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|November 6, 2019
Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet TherapyNina Wolska, Marcin Rozalski
Redox Biology|March 31, 2022
The amyloid peptide β disrupts intercellular junctions and increases endothelial permeability in a NADPH oxidase 1-dependent mannerAnuradha Tarafdar, Nina Wolska, Christoph Krisp, et al.
Pharmaceuticals (Basel, Switzerland)|August 6, 2020
Adenosine Receptor Agonists Increase the Inhibition of Platelet Function by P2Y<sub>12</sub> Antagonists in a cAMP- and Calcium-Dependent MannerNina Wolska, Hassan Kassassir, Boguslawa Luzak, et al.
International Journal of Molecular Sciences|September 10, 2021
Sample Preparation as a Critical Aspect of Blood Platelet Mitochondrial Respiration Measurements-The Impact of Platelet Activation on Mitochondrial RespirationKarolina Siewiera, Magdalena Labieniec-Watala, Nina Wolska, et al.
Vascular Pharmacology|November 25, 2018
Adenosine receptor agonists deepen the inhibition of platelet aggregation by P2Y<sub>12</sub> antagonistsMagdalena Boncler, Joanna Wzorek, Nina Wolska, et al.
Journal of Pharmacological and Toxicological Methods|July 23, 2018
Comparison of different microscopy approaches to quantification of inhibitory effect on thrombus formation under flow conditions by the example of adenosine receptor agonist HE-NECATomasz Przygodzki, Nina Wolska, Marcin Talar, et al.
Journal of Clinical Medicine|September 9, 2022
Platelet-Derived Procoagulant Microvesicles Are Elevated in Patients with Retinal Vein Occlusion (RVO)Adrianna Marcinkowska, Nina Wolska, Boguslawa Luzak, et al.
International Journal of Molecular Sciences|April 12, 2022
Potential Role of Mitochondria as Modulators of Blood Platelet Activation and Reactivity in Diabetes and Effect of Metformin on Blood Platelet Bioenergetics and Platelet ActivationKarolina Siewiera, Magdalena Labieniec-Watala, Hassan Kassassir, et al.
Antioxidants (Basel, Switzerland)|May 5, 2021
Diabetes and Thrombosis: A Central Role for Vascular Oxidative StressAishwarya R Vaidya, Nina Wolska, Dina Vara, et al.
Biochemical and Biophysical Research Communications|April 9, 2020
P2Y<sub>12</sub> receptor antagonists and AR receptor agonists regulates Protein Disulfide Isomerase secretion from platelets and endothelial cellsMarcin Popielarski, Halszka Ponamarczuk, Marta Stasiak, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|November 6, 2019
Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet TherapyNina Wolska, Marcin Rozalski
Redox Biology|March 31, 2022
The amyloid peptide β disrupts intercellular junctions and increases endothelial permeability in a NADPH oxidase 1-dependent mannerAnuradha Tarafdar, Nina Wolska, Christoph Krisp, et al.
Pharmaceuticals (Basel, Switzerland)|August 6, 2020
Adenosine Receptor Agonists Increase the Inhibition of Platelet Function by P2Y<sub>12</sub> Antagonists in a cAMP- and Calcium-Dependent MannerNina Wolska, Hassan Kassassir, Boguslawa Luzak, et al.
International Journal of Molecular Sciences|September 10, 2021
Sample Preparation as a Critical Aspect of Blood Platelet Mitochondrial Respiration Measurements-The Impact of Platelet Activation on Mitochondrial RespirationKarolina Siewiera, Magdalena Labieniec-Watala, Nina Wolska, et al.
Vascular Pharmacology|November 25, 2018
Adenosine receptor agonists deepen the inhibition of platelet aggregation by P2Y<sub>12</sub> antagonistsMagdalena Boncler, Joanna Wzorek, Nina Wolska, et al.
Journal of Pharmacological and Toxicological Methods|July 23, 2018
Comparison of different microscopy approaches to quantification of inhibitory effect on thrombus formation under flow conditions by the example of adenosine receptor agonist HE-NECATomasz Przygodzki, Nina Wolska, Marcin Talar, et al.
Journal of Clinical Medicine|September 9, 2022
Platelet-Derived Procoagulant Microvesicles Are Elevated in Patients with Retinal Vein Occlusion (RVO)Adrianna Marcinkowska, Nina Wolska, Boguslawa Luzak, et al.
International Journal of Molecular Sciences|April 12, 2022
Potential Role of Mitochondria as Modulators of Blood Platelet Activation and Reactivity in Diabetes and Effect of Metformin on Blood Platelet Bioenergetics and Platelet ActivationKarolina Siewiera, Magdalena Labieniec-Watala, Hassan Kassassir, et al.
Antioxidants (Basel, Switzerland)|May 5, 2021
Diabetes and Thrombosis: A Central Role for Vascular Oxidative StressAishwarya R Vaidya, Nina Wolska, Dina Vara, et al.
Biochemical and Biophysical Research Communications|April 9, 2020
P2Y<sub>12</sub> receptor antagonists and AR receptor agonists regulates Protein Disulfide Isomerase secretion from platelets and endothelial cellsMarcin Popielarski, Halszka Ponamarczuk, Marta Stasiak, et al.
Pageof 3